Acetamide, N-(4-hydroxyphenyl)- | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Acetamide, N-(4-hydroxyphenyl)-
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Paracetamol

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Acetamide, N-(4-hydroxyphenyl)-

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

257 API Suppliers, 80 USDMF, 21 CEP/COS, 16 JDMF, 9 EU WC, 108 KDMF, 108 NDC API, 33 Listed Suppliers, $ API Reference Price

257 API Suppliers
80 USDMF
21 CEP/COS
16 JDMF
9 EU WC
108 KDMF
108 NDC API
33 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

370 Drugs in Development

370 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2685 FDF Dossiers, 734 FDA Orange Book, 501 Europe, 292 Canada, 71 Australia, 402 South Africa, 685 Listed Dossiers

2685 FDF Dossiers
734 FDA Orange Book
501 Europe
292 Canada
71 Australia
402 South Africa
685 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUPPOSITORY;RECTAL - 120MG, SUPPOSITORY;RECTAL - 325MG, SUPPOSITORY;RECTAL - 650MG, SUPPOSITORY;RECTAL - 80MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 325MG;37.5MG, SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 300MG;60MG

SUPPOSITORY;RECTAL - 120MG
SUPPOSITORY;RECTAL - 325MG
SUPPOSITORY;RECTAL - 650MG
SUPPOSITORY;RECTAL - 80MG
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 250MG;250MG;65MG
TABLET;ORAL - 325MG;37.5MG
SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG;15MG
TABLET;ORAL - 300MG;30MG
TABLET;ORAL - 300MG;60MG
TABLET;ORAL - 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 325MG;50MG;40MG
TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Minakem, 1 Evonik, 13 Rochem International Inc, 32 SPI Pharma, 37 DKSH, 2 Pharm-RX Chemical, 14 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 21 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 14 Kirsch Pharma, 4 ACG Worldwide, 19 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 44 BASF, 8 Beneo, 2 Bioplus Life Sciences, 6 CD Formulation, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 4 Finar, 17 Gangwal Chemicals, 2 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 27 Microlex e.U, 2 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 12 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 56 Roquette, 22 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

127 Fillers, Diluents & Binders, 92 Thickeners and Stabilizers, 73 Solubilizers, 64 Coating Systems & Additives, 60 Taste Masking, 59 Topical, 55 Direct Compression, 54 Parenteral, 50 Disintegrants & Superdisintegrants, 45 Granulation, 39 Lubricants & Glidants, 38 Film Formers & Plasticizers, 35 Controlled & Modified Release, 28 Emulsifying Agents, 28 Chewable & Orodispersible Aids, 24 Rheology Modifiers, 18 Co-Processed Excipients, 17 Surfactant & Foaming Agents, 12 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

127 Fillers, Diluents & Binders
92 Thickeners and Stabilizers
73 Solubilizers
64 Coating Systems & Additives
60 Taste Masking
59 Topical
55 Direct Compression
54 Parenteral
50 Disintegrants & Superdisintegrants
45 Granulation
39 Lubricants & Glidants
38 Film Formers & Plasticizers
35 Controlled & Modified Release
28 Emulsifying Agents
28 Chewable & Orodispersible Aids
24 Rheology Modifiers
18 Co-Processed Excipients
17 Surfactant & Foaming Agents
12 API Stability Enhancers
9 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 356 News #PharmaBuzz

2 Data Compilation #PharmaFlow
356 News #PharmaBuzz

GLOBAL SALES INFORMATION

94 US Medicaid Prescriptions, 403 Regulatory FDF Prices, 21 Annual Reports

94 US Medicaid Prescriptions
403 Regulatory FDF Prices
21 Annual Reports

MARKET PLACE

188 APIs, 95 FDF Dossiers

188 APIs
95 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 2 US Exclusivities, 7 Health Canada Patents

41 US Patents
2 US Exclusivities
7 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 JP, 26 Others

1 EDQM
1 JP
26 Others

ANALYTICAL

2 BioAnalytical Methods, 8 Analytical Methods

2 BioAnalytical Methods
8 Analytical Methods

$ API Ref.Price (USD/KG) : 7 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 3BioSyent Pharma Inc..

02 1Janssen Inc.

03 1Mallinckrodt Canada

04 2Mallinckrodt Pharmaceuticals Inc

filter Patent Reset all filters

7 All

01 12095523

02 12233924

03 12415403

04 22570474

05 12705733

06 12955557

filter Product Reset all filters

7 All

01 1ACETAMINOPHEN | IBUPROFEN

02 2ACETAMINOPHEN | IBUPROFEN SODIUM DIHYDRATE

03 3Acetaminophen

04 1Tramadol | Acetaminophen

filter Dosage Reset all filters

7 All

01 2SOLUTION

02 3Solution

03 1TABLET

04 1Tablet

filter Exp Date Reset all filters

7 All

01 12012-09-03

02 12017-08-05

03 12021-06-06

04 22025-07-07

05 12028-11-13

06 12035-07-17

Granules Paracetamol

Product Main Page

01

Janssen Inc.

Tramadol Hydrochloride, Paracetamol

CPhI Korea

Not Confirmed

Janssen Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-09-03

Date Granted : 2004-06-22

Tramadol Hydrochloride, Paracetamol

Brand Name : TRAMACET

Patent Number : 2095523

Filing Date : 1992-09-03

Strength per Unit : 37.5mg / 325mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-09-03

Date Granted : 2004-06-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Mallinckrodt Pharmaceuticals Inc

Paracetamol

CPhI Korea

Not Confirmed

Mallinckrodt Pharmaceuticals Inc

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-06-06

Date Granted : 2011-05-24

Paracetamol

Brand Name : OFIRMEV

Patent Number : 2415403

Filing Date : 2001-06-06

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2021-06-06

Date Granted : 2011-05-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Mallinckrodt Canada

Paracetamol

CPhI Korea

Not Confirmed

Mallinckrodt Canada

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-08-05

Date Granted : 2012-08-21

Paracetamol

Brand Name : OFIRMEV

Patent Number : 2233924

Filing Date : 1997-08-05

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2017-08-05

Date Granted : 2012-08-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Mallinckrodt Pharmaceuticals Inc

Paracetamol

CPhI Korea

Not Confirmed

Mallinckrodt Pharmaceuticals Inc

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-11-13

Date Granted : 2015-02-03

Paracetamol

Brand Name : OFIRMEV

Patent Number : 2705733

Filing Date : 2008-11-13

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2028-11-13

Date Granted : 2015-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BioSyent Pharma Inc..

Paracetamol, Ibuprofen

CPhI Korea

Not Confirmed

BioSyent Pharma Inc..

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-07

Date Granted : 2010-01-05

Paracetamol, Ibuprofen

Brand Name : COMBOGESIC

Patent Number : 2570474

Filing Date : 2005-07-07

Strength per Unit : 325 mg / 97.5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-07-07

Date Granted : 2010-01-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

BioSyent Pharma Inc..

Paracetamol, Ibuprofen Sodium

CPhI Korea

Not Confirmed

BioSyent Pharma Inc..

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-07

Date Granted : 2010-01-05

Paracetamol, Ibuprofen Sodium

Brand Name : COMBOGESIC IV

Patent Number : 2570474

Filing Date : 2005-07-07

Strength per Unit : 10mg / mL, 3mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-07-07

Date Granted : 2010-01-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

BioSyent Pharma Inc..

Paracetamol, Ibuprofen Sodium

CPhI Korea

Not Confirmed

BioSyent Pharma Inc..

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-17

Date Granted : 2021-06-22

Paracetamol, Ibuprofen Sodium

Brand Name : COMBOGESIC IV

Patent Number : 2955557

Filing Date : 2015-07-17

Strength per Unit : 10mg / mL, 3mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2035-07-17

Date Granted : 2021-06-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!